Explore our science.
You are not alone in the battle against cancer.
Learn about the next generation in precision oncology.
Learn more about our clinical trials and how you can contribute to the future of cancer care.
We are a next generation radiopharmaceutical company, taking cancer head on.
Precision is the future of cancer care. Radiopharmaceutical products could offer new hope to patients with cancer.
We are pushing forward the next-generation of radiopharmaceuticals with our exciting pipeline.
With focus and precision, our products direct the power of high energy particles towards cancer - and only cancer.
Learn more about our ongoing study for Men with Metastatic Castration-Resistant Prostate Cancer. Now enrolling in phase 3.
POINT today announced management will participate in the following upcoming investor conferences
Enrollment for the randomization phase of SPLASH completed prior to EOY 2022, meeting previous guidance